Human Albumin 20% I.P. – Long Description and Use in Cancer Care
Human Albumin 20% I.P. is a concentrated intravenous albumin solution prepared from qualified human plasma. Albumin is the main protein naturally present in blood plasma and plays an important role in maintaining oncotic pressure, circulating blood volume, and fluid balance within the body.
Scotalbu Human Albumin 20% I.P. contains 20 g of human albumin in 100 ml and is intended for intravenous use only under the supervision of a qualified healthcare professional.
Role of Human Albumin in Cancer Treatment
Human albumin is not an anticancer medicine and does not directly destroy or control cancer cells. However, it may be used as part of supportive care in selected patients with cancer when clinically indicated.
Cancer patients can sometimes develop low blood albumin levels because of poor nutritional intake, inflammation, advanced disease, liver dysfunction, protein loss, major surgery, infections, or other complications. In such situations, physicians may consider albumin therapy depending on the patient’s overall medical condition.
Human Albumin 20% may be considered in hospital settings for:
- Management of significant hypoalbuminemia in selected patients when albumin replacement is clinically appropriate.
- Support of circulating blood volume in patients with volume depletion when the treating physician determines that a colloid solution is required.
- Management of fluid balance in certain patients with severe edema or abnormal fluid distribution.
- Supportive treatment in critically ill oncology patients when low circulating volume or albumin deficiency is present.
- Cancer-related or liver-related ascites management in specific clinical situations, particularly when albumin administration is recommended as part of a procedure or treatment protocol.
- Post-operative support following major cancer surgery when albumin replacement or plasma-volume support is clinically indicated.
- Support during severe infections, sepsis, or other complications in oncology patients when albumin is considered appropriate by the treating medical team.
Human Albumin and Cancer-Related Ascites
Some patients with advanced cancer may develop ascites, which is an abnormal accumulation of fluid in the abdomen. Albumin may occasionally be used as part of the management of fluid shifts or after removal of large amounts of abdominal fluid, depending on the cause of ascites and the patient’s clinical condition.
Its use in malignant ascites is not automatic or routine and should be determined by the treating oncologist or physician.
Important Information
Human Albumin should only be administered in a hospital or supervised healthcare setting. Dosage and infusion rate vary according to the patient’s age, body weight, blood volume, albumin level, cardiovascular status, kidney function, and clinical condition.
Patients receiving albumin may require monitoring of blood pressure, pulse, urine output, electrolytes, hydration status, and signs of fluid overload.
Possible adverse reactions can include fever, chills, nausea, flushing, rash, allergic reactions, changes in blood pressure, or fluid overload. Rarely, serious hypersensitivity reactions may occur.
Product Information
Product Name: Human Albumin 20% I.P.
Brand Name: Scotalbu
Strength: 20%
Content: 20 g / 100 ml
Dosage Form: Solution for Infusion
Route: Intravenous use only
Source: Manufactured from qualified human plasma
Marketed by: Scotmed Care (P) Limited
Note: Human Albumin is a prescription plasma-derived medicinal product. Its use in patients with cancer should be based on a physician’s assessment and appropriate clinical guidelines. It should not be presented as a treatment for cancer itself.
Human Albumin 20% I.P. 100 ml (SCOTALBU 20% Solution) is a sterile human albumin preparation manufactured from qualified human plasma and intended for intravenous administration. Each 100 ml contains 20 g of Human Albumin, providing a 20% albumin solution.
SCOTALBU is supplied for professional healthcare and institutional requirements. Scotmed Care supports B2B pharmaceutical supply, hospital and institutional procurement, distributor requirements, and bulk orders, subject to applicable licenses and regulatory requirements.
Product Highlights
- Composition: Human Albumin 20% I.P.
- Strength: 20 g/100 ml
- Pack Size: 100 ml
- Dosage Form: Solution for Infusion
- Route: For IV Use Only
- Manufactured from qualified human plasma
- Sterile pharmaceutical preparation
- Suitable for hospital and institutional procurement
- B2B and bulk supply support available
Important: This is a prescription product intended for use under the supervision of a qualified healthcare professional. Storage, administration, dosage, and handling should be according to the approved product information and prescribing guidance.
